Full Spectrum is a seasoned player in the Health Care industry, offering end-to-end product development and testing services for Medical Device, Life Sciences, Evolving Healthcare, and Regulated Robotics. With over 40 years of experience and a track record of more than 1,000 successfully completed development programs, including advanced medical devices, robotics, and algorithm-based systems, the company has established itself as a reliable partner in the sector.
Notably, Full Spectrum has been ISO 13485 certified since 2009, underscoring its commitment to quality and compliance. After its inception in 1982, the company has upheld its presence and influence in the industry, displaying resilience and adaptability. Its recent Private Equity Round investment in March 2021, which saw participation from Massachusetts Capital Resource Company and Pine Street Capital Partners, further attests to its appeal to investors and the perceived value of its offerings.
Based in the United States, Full Spectrum continues to demonstrate its significance in the evolving landscape of healthcare technology, making it an appealing prospect for venture capitalists seeking investment opportunities in the sector.